featured
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small-Vessel Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial
JAMA Neurol 2023 May 24;[EPub Ahead of Print], JM Wardlaw, LJ Woodhouse, II Mhlanga, K Oatey, AK Heye, J Bamford, V Cvoro, FN Doubal, T England, A Hassan, A Montgomery, JT O'Brien, C Roffe, N Sprigg, DJ Werring, PM BathFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.